Top

Published in:

01-12-2013

Feasibility and efficacy of a supervised exercise intervention in de-conditioned cancer survivors during the early survivorship phase: the PEACH trial

Authors: J. M. Broderick, E. Guinan, M. J. Kennedy, D. Hollywood, K. S. Courneya, S. N. Culos-Reed, K. Bennett, D. M. O’ Donnell, J. Hussey

Published in: Journal of Cancer Survivorship | Issue 4/2013

Abstract

Purpose

This study aims to evaluate the feasibility and efficacy of an 8-week supervised exercise program in de-conditioned cancer survivors within 2–6 months of chemotherapy completion.

Methods

Participants were randomly assigned to an 8-week, twice-weekly, supervised aerobic exercise training regime (n = 23) or a usual care group (n = 20). Feasibility was assessed by recruitment rate, program adherence and participant feedback. The primary outcome was aerobic fitness assessed by the Modified Bruce fitness test at baseline (0 weeks), post-intervention (8 weeks) and at 3-month follow-up. Secondary outcomes included physical activity, waist circumference, fatigue and quality of life.

Results

The recruitment rate was 81 % and adherence to the supervised exercise was 78.3 %. Meaningful differences in aerobic fitness between the exercise and usual care groups at both the 8-week [mean 3.0 mL kg⁻¹ min⁻¹ (95 % CI −1.1–7.0)] and 3-month follow-up [2.1 mL kg⁻¹ min⁻¹ (−2.3–6.6)] were found, although these differences did not achieve statistical significance (p values >0.14). Self-reported physical activity increased in the exercise group (EG) compared to the usual care group at both 8-week (p = 0.01) and 3-month follow-up (p = 0.03) and significant differences in favour of the EG were found for physical well-being at both the 8-week (p = 0.03) and 3-month follow-up (p = 0.04). Improvements in fatigue (p = 0.01), total quality of life plus fatigue (p = 0.04), and a composite physical functioning score (p = 0.01) at the 3-month follow-up were also found.

Conclusion

The PEACH trial suggests that 8 weeks of supervised aerobic exercise training was feasible and may improve aerobic fitness, fatigue and quality of life in de-conditioned cancer survivors during the early survivorship phase.

Implications for Cancer Survivors

Exercise interventions commenced in the early survivorship phase appear safe, feasible and may lead to improvements in QOL and fatigue.

Das P, Horton R. Rethinking our approach to physical activity. Lancet. 2012;380(9838):189–90. doi:10.1016/s0140-6736(12)61024-1.PubMedCrossRef

Spence RR, Heesch KC, Brown WJ. Exercise and cancer rehabilitation: a systematic review. Cancer Treat Rev. 2010;36(2):185–94. doi:10.1016/j.ctrv.2009.11.003.PubMedCrossRef

Ferrer RA, Huedo-Medina TB, Johnson BT, Ryan S, Pescatello LS. Exercise interventions for cancer survivors: a meta-analysis of quality of life outcomes. Ann Behav Med. 2011;41(1):32–47. doi:10.1007/s12160-010-9225-1.PubMedCrossRef

Jones LW, Liang Y, Pituskin EN, Battaglini CL, Scott JM, et al. Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysis. Oncologist. 2011;16(1):112–20. doi:10.1634/theoncologist.2010-0197.PubMedCrossRef

Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv. 2010;4(2):87–100. doi:10.1007/s11764-009-0110-5.PubMedCrossRef

Duijts SF, Faber MM, Oldenburg HS, van Beurden M, Aaronson NK. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors—a meta-analysis. Psychooncology. 2011;20(2):115–26. doi:10.1002/pon.1728.PubMedCrossRef

Courneya KS, Friedenreich CM. Framework PEACE: an organizational model for examining physical exercise across the cancer experience. Ann Behav Med. 2001;23(4):263–72.PubMedCrossRef

Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23(24):5814–30. doi:10.1200/jco.2005.01.230.PubMedCrossRef

Jones LW, Courneya KS, Mackey JR, Muss HB, Pituskin EN, et al. Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol. 2012;30(20):2530–7. doi:10.1200/jco.2011.39.9014.PubMedCrossRef

10.

Thorsen L, Skovlund E, Stromme SB, Hornslien K, Dahl AA, et al. Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy. J Clin Oncol. 2005;23(10):2378–88. doi:10.1200/jco.2005.04.106.PubMedCrossRef

11.

Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007;50(15):1435–41. doi:10.1016/j.jacc.2007.06.037.PubMedCrossRef

12.

McGowan EL, Speed-Andrews AE, Blanchard CM, Rhodes RE, Friedenreich CM, et al. Physical activity preferences among a population-based sample of colorectal cancer survivors. Oncol Nurs Forum. 2013;40(1):44–52. doi:10.1188/13.onf.44-52.PubMedCrossRef

13.

Vallance JK, Courneya KS, Jones LW, Reiman T. Exercise preferences among a population-based sample of non-Hodgkin’s lymphoma survivors. Eur J Cancer Care (Engl). 2006;15(1):34–43. doi:10.1111/j.1365-2354.2005.00617.x.CrossRef

14.

Karvinen KH, Courneya KS, Venner P, North S. Exercise programming and counseling preferences in bladder cancer survivors: a population-based study. J Cancer Surviv. 2007;1(1):27–34. doi:10.1007/s11764-007-0010-5.PubMedCrossRef

15.

Karvinen KH, Courneya KS, Campbell KL, Pearcey RG, Dundas G, et al. Exercise preferences of endometrial cancer survivors: a population-based study. Cancer Nurs. 2006;29(4):259–65.PubMedCrossRef

16.

Courneya KS, Friedenreich CM. Physical activity and cancer control. Semin Oncol Nurs. 2007;23(4):242–52. doi:10.1016/j.soncn.2007.08.002.PubMedCrossRef

17.

Irwin ML, Crumlet D, Mc Tiernan A. Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity (HEAL) study. Cancer. 2003;97(7):1746–57.PubMedCrossRef

18.

Matthews CE, Wilcox S, Hanby CL, Der Ananian C, Heiney SP, et al. Evaluation of a 12-week home-based walking intervention for breast cancer survivors. Support Care Cancer. 2007;15(2):203–11. doi:10.1007/s00520-006-0122-x.PubMedCrossRef

19.

Nikander R, Sievanen H, Ojala K, Oivanen T, Kellokumpu-Lehtinen PL, et al. Effect of a vigorous aerobic regimen on physical performance in breast cancer patients—a randomized controlled pilot trial. Acta Oncol. 2007;46(2):181–6. doi:10.1080/02841860600833145.PubMedCrossRef

20.

Trinh L, Plotnikoff RC, Rhodes RE, North S, Courneya KS. Physical activity preferences in a population-based sample of kidney cancer survivors. Support Care Cancer. 2012;20(8):1709–17. doi:10.1007/s00520-011-1264-z.PubMedCrossRef

21.

Vallance JK, Courneya KS, Jones LW, Reiman T. Exercise preferences among a population-based sample of non-Hodgkin’s lymphoma survivors. Eur J Cancer Care. 2005;15:34–43.CrossRef

22.

Jones L, Courneya KS. Exercise counseling and programming preferences of cancer survivors. Cancer Pract. 2002;10:208–15.PubMedCrossRef

23.

Rogers LQ, Markwell SJ, Verhulst S, McAuley E, Courneya KS. Rural breast cancer survivors: exercise preferences and their determinants. Psychooncology. 2009;18(4):412–21. doi:10.1002/pon.1497.PubMedCrossRef

24.

Walsh JM, Hussey J, Guinan E, O’Donnell D. 'Pragmatic randomized controlled trial of individually prescribed exercise versus usual care in a heterogeneous cancer survivor population': a feasibility study PEACH trial: prescribed exercise after chemotherapy. BMC Cancer. 2010;10:42. doi:10.1186/1471-2407-10-42.PubMedCrossRef

25.

Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, et al. Exercise standards for testing and training. A statement for healthcare professionals from the American Heart Association. Circulation. 2001;104:1694–740.PubMedCrossRef

26.

Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–81.PubMedCrossRef

27.

Ajzen I. The theory of planned behaviour. Organ Behav Hum Decis Process. 1991;50:179–211.CrossRef

28.

Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409–26. doi:10.1249/MSS.0b013e3181e0c112.PubMedCrossRef

29.

Fielding RA, Frontera WR, Hughes VA, Fisher EC, Evans WJ. The reproducibility of the Bruce protocol exercise test for the determination of aerobic capacity in older women. Med Sci Sports Exerc. 1997;29(8):1109–13.PubMedCrossRef

30.

Glass S, Dwyer G. ACSM’s metabolic calculations handbook. 1st ed. Baltimore: Lippincott Williams and Wilkins; 2006.

31.

McArdle WD, Katch FI, Katch FI. Essentials of exercise physiology. 4th ed: Lippincott Williams and Wilkins; 2010.

32.

Cella D, Tulsky DS, Gray G, Sarafin B, Linn E, et al. The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9.PubMed

33.

Cella D, Eton DT, Lai JS. Combining anchor and distribution based methods to derive clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage. 2002;24:547–61.PubMedCrossRef

34.

Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol. 1997;34(3 Suppl 2):13–9.PubMed

35.

Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey. Manual and interpretation guide. Boston: The Health institute, New England Medical Center; 1993.

36.

Ware JE, Kosinski M, Dewey JE. How to score Version Two of the SF-36 Health Survey. Lincoln: Quality Metric; 2000.

37.

Rowlands AV, Thomas PWM, Eston RG, Topping R. Validation of the RT3 triaxial accelerometer for the assessment of physical activity. Med Sci Sports Exerc. 2004;36(3):518–24. doi:10.1249/01.MSS.0000117158.14542.E7.PubMedCrossRef

38.

Powell SMP, Rowlands AV. Inter-monitor variability of the RT3 accelerometer during a variety of physical activities. Med Sci Sports Exerc. 2004;36:324–30. doi:10.1249/01.MSS.0000113743.68789.36.PubMedCrossRef

39.

Trost SG, McIver KL, Pate RR. Conducting accelerometer-based activity assessments in field-based research. Med Sci Sports Exerc. 2005;37(11 Suppl):S531–43.PubMedCrossRef

40.

Matthews CE, Chen KY, Freedson PS, Buchowski MS, Beech BM, et al. Amount of time spent in sedentary behaviors in the United States, 2003–2004. Am J Epidemiol. 2008;167(7):875–81. doi:10.1093/aje/kwm390.PubMedCrossRef

41.

Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, et al. Physical activity and public health: updated recommendations for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116:1081–93. doi:10.1161/CIRCULATIONAHA.107.185649.PubMedCrossRef

42.

Godin G, Shephard RJ. A simple method to assess exercise behaviour in the community. Can J Appl Sports Sci. 1985;10:141–6.

43.

Godin G, Shephard RJ. Godin Leisure-Time Exercise Questionnaire. Med Sci Sports Exerc. 1997;29 June Supplement:S36–S8.

44.

Borm GF, Fransen J, Lemmens WA. A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol. 2007;60(12):1234–8. doi:10.1016/j.jclinepi.2007.02.006.PubMedCrossRef

45.

Stevinson C, Lawlor DA, Fox KR. Exercise interventions for cancer patients: systematic review of controlled trials. Cancer Causes Control. 2004;15(10):1035–56.PubMedCrossRef

46.

Milne HM, Wallman KE, Gordon S, Courneya KS. Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat. 2008;108(2):279–88. doi:10.1007/s10549-007-9602-z.PubMedCrossRef

47.

Courneya KS, Friedenreich CM. Physical activity and cancer control. Semin Oncol. 2007;23(4):242–52.CrossRef

48.

Myers J, Prakash M, Froelicher V. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793–801.PubMedCrossRef

49.

Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, et al. Randomized controlled trial of exercise training in post-menopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol. 2003;21:1660–8.PubMedCrossRef

50.

Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol. 2009;27(27):4605–12. doi:10.1200/jco.2008.20.0634.PubMedCrossRef

51.

McNeely ML. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. Can Med Assoc J. 2006;175(1):34–41. doi:10.1503/cmaj.051073.CrossRef

52.

Dimeo FC, Stieglitz RD, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and physiologic status of cancer patients during chemotherapy. Cancer. 1999;85:2273–7.PubMedCrossRef

53.

Pinto BM, Frierson GM, Rabin C, Trunzo JJ, Marcus BH. Home-based physical activity intervention for breast cancer patients. J Clin Oncol. 2005;23(15):3577–87. doi:10.1200/jco.2005.03.080.PubMedCrossRef

54.

Rogers LQ, Hopkins-Price P, Vicari S, Pamenter R, Courneya KS, et al. A randomized trial to increase physical activity in breast cancer survivors. Med Sci Sports Exerc. 2009;41(4):935–46. doi:10.1249/MSS.0b013e31818e0e1b.PubMedCrossRef

55.

Vallance JK, Courneya KS, Plotnikoff RC, Yasui Y, Mackey JR. Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors. J Clin Oncol. 2007;25(17):2352–9. doi:10.1200/jco.2006.07.9988.PubMedCrossRef

Title: Feasibility and efficacy of a supervised exercise intervention in de-conditioned cancer survivors during the early survivorship phase: the PEACH trial
Authors: J. M. Broderick
E. Guinan
M. J. Kennedy
D. Hollywood
K. S. Courneya
S. N. Culos-Reed
K. Bennett
D. M. O’ Donnell
J. Hussey
Publication date: 01-12-2013
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 4/2013
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-013-0294-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Implications for Cancer Survivors

Please log in to get access to this content

Other articles of this Issue 4/2013

Validity of self-reported genetic counseling and genetic testing use among breast cancer survivors

Trends in modifiable lifestyle-related risk factors following diagnosis in breast cancer survivors

A qualitative synthesis of trials promoting physical activity behaviour change among post-treatment breast cancer survivors

Why do some patients prefer to leave decisions up to the doctor: lack of self-efficacy or a matter of trust?

Type of hematological malignancy is crucial for the return to work prognosis: a register-based cohort study

Health-related quality of life, lifestyle behaviors, and intervention preferences of survivors of childhood cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer